About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
The Hematology Journal
›
Top Articles
The Hematology Journal
Hematology
(top 60%)
Impact Factor
(top 60%)
extended IF
43
(top 9%)
H-Index
251
authors
413
papers
8K
citations
1.7K
citing journals
5.3K
citing authors
Most Cited Articles of The Hematology Journal
Title
Year
Citations
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
2003
317
Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML
2003
182
The effect of iron deficiency anemia on the function of the immune system
2005
160
Mesenchymal stem cell: use and perspectives
2003
145
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma
2004
117
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma
2004
111
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma
2004
110
Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants
2001
110
The 5TMM series: a useful in vivo mouse model of human multiple myeloma
2000
102
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib
2004
100
A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma
2002
89
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis
2004
88
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?
2000
86
Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention?
2004
85
Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma
2001
84
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
2003
80
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment
2001
77
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas
2004
75
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma
2000
75
Patterns of mortality in sickle cell disease in adults in France and England
2002
74
Role of coagulation testing in predicting bleeding risk
2003
71
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients
2001
70
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies
2001
67
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM)
2002
61
Nuclear transplantation, embryonic stem cells and the potential for cell therapy
2004
59
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.